We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CVSH34 market cap is 41.18B. The company's latest EPS is USD 6.4838 and P/E is 9.29.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 85.28B | 88.92B | 89.76B | 93.81B | 88.44B |
| Operating Income | 3.8B | 3.23B | 3.69B | 3.37B | 2.27B |
| Net Income | 2.14B | 1.9B | 2.26B | 2.05B | 1.11B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 256.78B | 268.71B | 292.11B | 322.47B | 357.78B |
| Operating Income | 11.99B | 13.91B | 14.55B | 10.28B | 14.09B |
| Net Income | 6.63B | 7.19B | 7.91B | 4.15B | 8.34B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 239.33B | 250.07B | 251.31B | 249.73B | 249.74B |
| Total Liabilities | 167.75B | 177.07B | 176.8B | 173.09B | 175.59B |
| Total Equity | 71.58B | 73B | 74.51B | 76.64B | 74.15B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 222.45B | 230.72B | 233B | 228.28B | 249.73B |
| Total Liabilities | 158.28B | 161.01B | 157.62B | 156.96B | 173.09B |
| Total Equity | 64.17B | 69.7B | 75.38B | 71.32B | 76.64B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.44B | 13.35B | 16.06B | 13.43B | 4.9B |
| Investing | -8.51B | -18.88B | -19.65B | -20.89B | -2.09B |
| Financing | 2.73B | 6.35B | 3.66B | 2.68B | -1.23B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 12.85B | 15.87B | 18.27B | 16.18B | 13.43B |
| Investing | -3.34B | -5.53B | -5.26B | -5.05B | -20.89B |
| Financing | -7.85B | -8.16B | -11.36B | -10.52B | 2.68B |
| Market Cap | 41.18B |
| Price to Earnings Ratio | 9.29 |
| Price to Sales Ratio | 0.22 |
| Price to Cash Ratio | 9.46 |
| Price to Book Ratio | 1.01 |
| Dividend Yield | 3.00% |
| Shares Outstanding | 1.29B |
| Average Volume (1 week) | 381 |
| Average Volume (1 Month) | 554 |
| 52 Week Change | -3.26% |
| 52 Week High | 40.43 |
| 52 Week Low | 27.57 |
| Spread (Intraday) | 4.98 (14.22%) |
| Company Name | CVS Health DRN |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cvshealth.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
